Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects.

R. Riva, F. Albani, A. Baruzzi

Research output: Contribution to journalArticle

Abstract

The management of epilepsy has been markedly improved during the last twenty years, although no new drug has been developed. These therapeutic advantages have been made possible by applying the concept of "therapeutic range" of antiepileptic drugs. This range was the result of some pioneer studies showing a good relationship between clinical effects and drug concentrations. Today, the approach to the drug therapy of epilepsy is heavily dependent on the application of this concept. Infact, important factors as patient compliance, variability in drug bioavailability and drug metabolism, drug interactions, disease interactions, etc, that may influence the clinical effect of a given dose, may be controlled by regular monitoring of antiepileptic drugs. However, the concept of "therapeutic range" should not be applied mechanically to patient treatment. The best results are obtained when the analytical results, the therapeutic situation and the clinical status of the patient are considered together. In this case, an important improvement of the quality of life of the epileptic patients can be reached.

Original languageEnglish
Pages (from-to)663-670
Number of pages8
JournalFarmaco
Volume47
Issue number5 Suppl
Publication statusPublished - May 1992

Fingerprint

Anticonvulsants
Pharmaceutical Preparations
Epilepsy
Therapeutics
Patient Compliance
Drug Interactions
Biological Availability
Quality of Life
Drug Therapy

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmaceutical Science

Cite this

Riva, R., Albani, F., & Baruzzi, A. (1992). Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects. Farmaco, 47(5 Suppl), 663-670.

Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects. / Riva, R.; Albani, F.; Baruzzi, A.

In: Farmaco, Vol. 47, No. 5 Suppl, 05.1992, p. 663-670.

Research output: Contribution to journalArticle

Riva, R, Albani, F & Baruzzi, A 1992, 'Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects.', Farmaco, vol. 47, no. 5 Suppl, pp. 663-670.
Riva R, Albani F, Baruzzi A. Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects. Farmaco. 1992 May;47(5 Suppl):663-670.
Riva, R. ; Albani, F. ; Baruzzi, A. / Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects. In: Farmaco. 1992 ; Vol. 47, No. 5 Suppl. pp. 663-670.
@article{5061f2961aae45d389a8b8fcd456772f,
title = "Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects.",
abstract = "The management of epilepsy has been markedly improved during the last twenty years, although no new drug has been developed. These therapeutic advantages have been made possible by applying the concept of {"}therapeutic range{"} of antiepileptic drugs. This range was the result of some pioneer studies showing a good relationship between clinical effects and drug concentrations. Today, the approach to the drug therapy of epilepsy is heavily dependent on the application of this concept. Infact, important factors as patient compliance, variability in drug bioavailability and drug metabolism, drug interactions, disease interactions, etc, that may influence the clinical effect of a given dose, may be controlled by regular monitoring of antiepileptic drugs. However, the concept of {"}therapeutic range{"} should not be applied mechanically to patient treatment. The best results are obtained when the analytical results, the therapeutic situation and the clinical status of the patient are considered together. In this case, an important improvement of the quality of life of the epileptic patients can be reached.",
author = "R. Riva and F. Albani and A. Baruzzi",
year = "1992",
month = "5",
language = "English",
volume = "47",
pages = "663--670",
journal = "Farmaco",
issn = "0014-827X",
publisher = "Societa chimica italiana",
number = "5 Suppl",

}

TY - JOUR

T1 - Therapeutic monitoring of antiepileptic drugs. I--Clinical aspects.

AU - Riva, R.

AU - Albani, F.

AU - Baruzzi, A.

PY - 1992/5

Y1 - 1992/5

N2 - The management of epilepsy has been markedly improved during the last twenty years, although no new drug has been developed. These therapeutic advantages have been made possible by applying the concept of "therapeutic range" of antiepileptic drugs. This range was the result of some pioneer studies showing a good relationship between clinical effects and drug concentrations. Today, the approach to the drug therapy of epilepsy is heavily dependent on the application of this concept. Infact, important factors as patient compliance, variability in drug bioavailability and drug metabolism, drug interactions, disease interactions, etc, that may influence the clinical effect of a given dose, may be controlled by regular monitoring of antiepileptic drugs. However, the concept of "therapeutic range" should not be applied mechanically to patient treatment. The best results are obtained when the analytical results, the therapeutic situation and the clinical status of the patient are considered together. In this case, an important improvement of the quality of life of the epileptic patients can be reached.

AB - The management of epilepsy has been markedly improved during the last twenty years, although no new drug has been developed. These therapeutic advantages have been made possible by applying the concept of "therapeutic range" of antiepileptic drugs. This range was the result of some pioneer studies showing a good relationship between clinical effects and drug concentrations. Today, the approach to the drug therapy of epilepsy is heavily dependent on the application of this concept. Infact, important factors as patient compliance, variability in drug bioavailability and drug metabolism, drug interactions, disease interactions, etc, that may influence the clinical effect of a given dose, may be controlled by regular monitoring of antiepileptic drugs. However, the concept of "therapeutic range" should not be applied mechanically to patient treatment. The best results are obtained when the analytical results, the therapeutic situation and the clinical status of the patient are considered together. In this case, an important improvement of the quality of life of the epileptic patients can be reached.

UR - http://www.scopus.com/inward/record.url?scp=0026859764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026859764&partnerID=8YFLogxK

M3 - Article

C2 - 1524620

AN - SCOPUS:0026859764

VL - 47

SP - 663

EP - 670

JO - Farmaco

JF - Farmaco

SN - 0014-827X

IS - 5 Suppl

ER -